GL1X · GenesisL1 explorer

Research workbench

RIP2 kinase catalytic domain complex with (5S,6S,8R)-2- (BENZO[D]THIAZOL-5-yl)-6-hydroxy-4,5,6,7,8,9-hexahydro-5,8- METHANOPYRAZOLO[1,5-A][1,3]DIAZOCINE-3-carboxamide

Analyse RIP2 kinase catalytic domain complex with (5S,6S,8R)-2… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6UL8
Type
protein
Length
562 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
O43353
Ligands
Q9J, CA

Structure

x-ray diffraction · 2 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein279—O43353
B—protein283—O43353

Ligands and binding sites

  • Q9J · (5S,6S,8R)-2-(1,3-benzothiazol-5-yl)-6-hydroxy-4,5,6,7, 8,9-hexahydro-5,8-methanopyrazolo[1,5-A][1, 3]diazocine-3-carboxamide · ligand · 2 copies · chains A, B
  • CA · Calcium ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 6UL8 · RIP2 kinase catalytic domain complex with (5S,6S,8R)-2-(benzo[d]thiazol-5-yl)-6-hydroxy-4… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.